Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 10/20 | 0.58 |
| ▸ | ESR1 | P03372 | 7/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | APP | P05067 | 1/20 | 0.34 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.33 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydroquinone SCHEMBL408939 | 0.85 | ESR2 (0.75) | ESR2ESR1CYP3A4CYP2C9CYP2D6 | |
| Di(Hydroxyethyl)Ether SCHEMBL6264148 | 0.85 | TSHR (0.56) | ESR2ESR1CYP3A4CYP2C9CYP2D6 | |
| Di(Hydroxyethyl)Ether SCHEMBL28229544 | 0.83 | TSHR (0.53) | ESR2ESR1CYP3A4CYP2C9CYP2D6 | |
| Hydroquinone SCHEMBL109119 | 0.82 | TSHR (0.59) | ESR2ESR1CYP3A4TSHRMAPK1 | |
| Hydroquinone SCHEMBL56540 | 0.82 | TSHR (0.59) | ESR2ESR1CYP3A4TSHRMAPK1 | |
| Hydroquinone SCHEMBL1815638 | 0.80 | TSHR (0.56) | ESR2ESR1CYP3A4TSHRMAPK1 | |
| Hydroquinone SCHEMBL6051296 | 0.76 | TSHR (0.50) | CYP3A4TSHRMAPK1MEN1KMT2A | |
| SCHEMBL578589 | 0.74 | APP (0.48) | CYP3A4MAPK1MEN1KMT2AAPP | |
| 1,6-Hexanediol SCHEMBL8674638 | 0.74 | TSHR (0.48) | CYP3A4TSHRMAPK1MEN1KMT2A | |
| SCHEMBL11314262 | 0.74 | TSHR (0.41) | ESR2ESR1CYP3A4CYP2C9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2271391-B1 | URETERAL STENTS FOR RELEASE OF UROLOGICALLY BENEFICIAL AGENTS | BOSTON SCIENT SCIMED INC (US) | 2019-10-30 | — | — | EP | disclosed |
| US-10251741-B2 | Ureteral stent with drug-releasing structure | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| EP-2294105-B1 | FIBER REINFORCED TPU COMPOSITES | LUBRIZOL ADVANCED MAT INC (US) | 2018-07-11 | — | — | EP | disclosed |
| US-20160361152-A1 | URETERAL STENT WITH DRUG-RELEASING STRUCTURE | BOSTON SCIENTIFIC SCIMED, INC. | 2016-12-15 | — | — | US | disclosed |
| US-9445884-B2 | Ureteral stent with drug-releasing structure | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2016-09-20 | — | — | US | disclosed |
| US-9068076-B2 | Fiber reinforced TPU composites | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2015-06-30 | — | — | US | disclosed |
| US-9029443-B2 | Non halogen flame retardant thermoplastic polyurethane | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-8940056-B2 | Ureteral stents for release of urologically beneficial agents | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2015-01-27 | — | — | US | disclosed |
| US-20140349111-A1 | Non Halogen Flame Retardant Thermoplastic Polyurethane | LUBRIZOL ADVANCED MAT INC (US) | 2014-11-27 | — | — | US | disclosed |
| US-20140214175-A1 | URETERAL STENT WITH DRUG-RELEASING STRUCTURE | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-07-31 | — | — | US | disclosed |
| US-20070292649-A1 | Multilayered Articles Having Biocompatibility And Biostability Characteristics | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2007-12-20 | — | — | US | disclosed |
| US-7264858-B2 | Multilayered articles having biocompatibility and biostability characteristics | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2007-09-04 | — | — | US | disclosed |
| WO-2006121549-A1 | NON HALOGEN FLAME RETARDANT THERMOPLASTIC POLYURETHANE | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2006-11-16 | — | — | WO | disclosed |
| EP-1235878-B1 | EXTRUDABLE POLYURETHANE COMPOSITIONS AND METHODS OF MAKING THEM | NOVEON IP HOLDINGS CORP (US) | 2005-12-28 | — | — | EP | disclosed |
| US-6777466-B2 | WIRE, CABLE JACKET; MOLDING MATERIALS; TENSILE STRENGTH | NOVEON IP HOLDINGS CORP. | 2004-08-17 | — | — | US | disclosed |
| WO-2004039584-A1 | MULTILAYERED ARTICLES HAVING BIOCOMPATIBILITY AND BIOSTABILITY CHARACTERISTICS | NOVEON IP HOLDINGS CORP. (US) | 2004-05-13 | — | — | WO | disclosed |
| US-20030166749-A1 | Flame retardant thermoplastic polyurethane containing melamine cyanurate | NOVEON, INC. | 2003-09-04 | — | — | US | disclosed |
| US-6458880-B1 | POLYESTERURETHANE COPOLYMERS WITH TALC FOR CRYSTALIZATION | NOVEON IP HOLDINGS CORP. | 2002-10-01 | — | — | US | disclosed |
| US-6297321-B1 | Extrudable polyurethane compositions and methods | THE B. F. GOODRICH COMPANY | 2001-10-02 | — | — | US | disclosed |
| US-5110850-A | Wires, cable jackets, blown films | B. F. GOODRICH COMPANY (US) | 1992-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10251741-B2 | Ureteral stent with drug-releasing structure | UTS2R, KDELR2, KDELR1 | ESR2 329/4885ESR1 126/4885CYP3A4 3731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.